Lung Diseases Cies Search Engine [selected websites]

Loading

Dec 21, 2009

Chart's CAIRE : Acquisition of Covidien's Oxygen Therapy Business

caire medicalNov. 30, 2009 - Chart Industries, Inc. (Nasdaq:GTLS) announced that CAIRE, which operates under Chart's BioMedical segment, has completed the previously announced acquisition of Covidien's (NYSE:COV) oxygen therapy business, including the design, manufacturing, and sales and service functions worldwide. CovidienThe acquisition includes products sold under the leading Companion(TM) and HELiOS(TM) brands. Financial terms of the transaction were not disclosed... Chart Industries' Press Release - Covidien's Press Release -